Aldeyra Therapeutics Cash Flow Statement (2013-2026) | ALDX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-35.84M	-27.38M	-16.07M	-18.58M	-18.97M	-19.03M	-13.15M	-41.50M	-25.96M	-15.18M	-5.05M	-8.08M	-16.85M	-22.02M	-15.76M	-17.60M	-10.49M	-14.02M	-6.62M	-3.45M
Depreciation and Depletion (Quarter)	0.07M	0.07M	0.06M	0.06M	0.06M	0.07M	0.07M	0.07M	0.06M	0.06M	0.07M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.07M	0.07M
Share-based Compensation (Quarter)	2.32M	1.42M	0.98M	1.94M	1.29M	2.24M	2.82M	4.19M	1.57M	0.79M	-6.02M	1.55M	1.94M	3.23M	1.26M	2.22M	0.20M	0.90M	5.79M	-0.99M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)																0.27M
Cash from Operations (Quarter)	-9.07M	-8.43M	-11.58M	-12.87M	-19.96M	-12.57M	-11.23M	-9.44M	-13.36M	-8.02M	0.50M	-9.97M	-13.22M	-7.97M	-12.04M	-12.47M	-8.56M	-7.02M	-5.30M	-5.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)		0.33M	0.08M	0.08M	0.08M	0.08M	0.08M	0.09M	0.10M	-0.17M	0.34M	0.06M	0.64M	-0.56M	1.54M	0.07M	0.77M	0.27M	-0.89M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.07M	0.06M	0.06M	0.06M	0.07M	0.07M	0.07M	0.06M	0.06M	0.07M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.07M	0.07M
Change in Working Capital
Change in Account Payables (Quarter)	0.65M	-0.63M	0.55M	1.42M	-0.67M	-0.47M	-1.17M	0.30M	-0.16M	-0.02M	1.09M	-1.06M	-0.03M	-0.07M	-0.01M	0.17M	0.68M	-1.02M	0.15M	-0.02M
Change in Accured Expenses (Quarter)	2.27M	3.65M	0.06M	2.94M	-2.87M	-1.33M	2.46M	-2.19M	-5.14M	-0.69M	-0.06M	0.49M	-0.35M	3.05M	1.82M	-5.17M	0.19M	-0.80M	-0.56M	-1.24M
Investing Activities
Capital Expenditures (Quarter)				0.02M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)					12.00M	24.00M	27.00M	30.00M					12.00M	20.00M	20.00M	23.00M	24.00M	25.00M	16.00M
Cash from Investing Activities (Quarter)				-58.03M	-17.94M	19.02M	27.00M	30.00M				-30.38M	-18.24M	5.26M	-1.56M	7.29M	-0.55M	25.00M	16.00M
Financing Activities
Other financing activities (Quarter)	0.61M	0.01M	-4.56M	0.02M		1.10M	-1.03M	0.05M	-0.05M	0.11M	0.08M				0.35M	0.02M			1.08M
Debt Issuance and Repayment
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	2.82M	4.56M	4.62M	5.97M	3.66M	3.35M	5.40M	6.43M	6.57M	6.17M	5.87M	4.52M	8.03M	5.12M	7.62M	8.34M	8.61M	8.59M	8.58M	10.01M
Net Equity Issued and Repurchased (Quarter)	119.80M
Misc.
Cash from Financing Activities (Quarter)	120.37M	0.06M		0.02M		1.20M		0.05M	0.01M	-0.32M	-1.01M	0.02M		-0.20M	0.01M	1.00M		0.12M		0.07M
Change in Cash (Quarter)	111.30M	-8.37M	-11.58M	-70.88M	-37.90M	7.64M	15.77M	20.61M	-13.35M	-8.34M	-0.51M	-40.33M	-31.46M	-2.91M	-13.59M	-4.18M	-9.11M	18.10M	10.70M	-5.04M
Free Cash Flow (Quarter)	-9.07M	-8.43M	-11.58M	-12.89M	-19.96M	-12.57M	-11.23M	-9.44M	-13.36M	-8.02M	0.50M	-9.97M	-13.22M	-7.97M	-12.04M	-12.47M	-8.56M	-7.02M	-5.30M	-5.11M
Net Cash Flow (Quarter)	111.30M	-8.37M	-11.58M	-70.88M	-37.90M	7.64M	15.77M	20.61M	-13.35M	-8.34M	-0.51M	-40.33M	-31.46M	-2.91M	-13.59M	-4.18M	-9.11M	18.10M	10.70M	-5.04M

Research Tools

Developers

Aldeyra Therapeutics Cash Flow Statement (2013-2026) | ALDX

Research Tools

Developers

Aldeyra Therapeutics Cash Flow Statement (2013-2026) | ALDX

Create an account

Sign In

Reset Password